Importance of Biomarkers in CMT

By Grace Pavlath, PhD Because CMT is often a slowly progressive disease, measuring the impact of a potential treatment during a typical clinical trial of 12-24 months can be elusive.  Current clinical outcome measures are inadequate in detecting such progression and...